S&W Seed reaffirms FY23 revenue view $80M-$92M vs $71.4M a year ago

Sees FY23 adjusted EBITDA ($7.0M)-($2.0M) vs. adjusted EBITDA of ($23.8M) in FY22. As the JV with Shell is expected to be accounted for as an equity method investment, the JV with Shell is not expected to have a material impact on S&W’s full-year financial results for FY23.